Nature Biotechnology 2000 Jeffrey L Fox - Abstracts

Title	Subject	Authors
Nature Biotechnology 2000 Jeffrey L Fox
Blood products part of FDA xenotransplant plan.	Business	Jeffrey L. Fox
Gene-therapy death prompts broad civil lawsuit.	Business	Jeffrey L. Fox
GM food singled out for labeling in the US.	Business	Jeffrey L. Fox
GM food singled out for labeling in the US.(Brief Article)	Business	Jeffrey L. Fox
Investigation of gene therapy begins.	Business	Jeffrey L. Fox
Lukewarm reception for US biotech proposals.	Business	Jeffrey L. Fox
NAS report: strengthen agbio regs and relations.	Business	Jeffrey L. Fox
Researches discuss NIH's nanotechnology initiative.(National Institutes of Health)	Business	Jeffrey L. Fox
Scrutiny of gene therapy broadens, intensifies.	Business	Jeffrey l. Fox
Scrutiny of gene therapy broadens, intensifies.(Brief Article)	Business	Jeffrey L. Fox
Sweeping bioethical reform proposals contemplated for trials.	Business	Jeffrey L. Fox
Taco dispute underscores need for standardized tests.	Business	Jeffrey L. Fox
Withdrawn Greenpeace Bt suit enters spin cycle.	Business	Jeffrey L. Fox

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.